+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anticonvulsants Market Research Report by Drug types, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5305569
  • Report
  • March 2021
  • Region: Global
  • 192 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
1 of 4
The Global Anticonvulsants Market to Grow USD 13,684.43 Million by 2025, at a CAGR of 7.68%

FEATURED COMPANIES

  • Abbott Laboratories
  • Biocon Limited
  • GlaxoSmithKline PLC
  • Lundbeck A/S
  • Merck KGaA
  • Novo Nordisk A/S
  • MORE
Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Anticonvulsants Market is expected to grow from USD 9,452.37 Million in 2020 to USD 13,684.43 Million by the end of 2025.
2. The Global Anticonvulsants Market is expected to grow from EUR 8,288.01 Million in 2020 to EUR 11,998.76 Million by the end of 2025.
3. The Global Anticonvulsants Market is expected to grow from GBP 7,368.06 Million in 2020 to GBP 10,666.93 Million by the end of 2025.
4. The Global Anticonvulsants Market is expected to grow from JPY 1,008,807.40 Million in 2020 to JPY 1,460,475.44 Million by the end of 2025.
5. The Global Anticonvulsants Market is expected to grow from AUD 13,726.09 Million in 2020 to AUD 19,871.61 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Anticonvulsants to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug types, the Anticonvulsants Market is examined across AMPA, Barbiturate, Benzodiazepine, Carbamate Anticonvulsants, Carbonic Anhydrase Inhibitor, Dibenzazepine, and Triazine.

Based on Application , the Anticonvulsants Market is examined across Anxiety, Bipolar Disorder, Borderline Personality Disorder., Epilepsy, Fibromyalgia, Migraine, and Neuropathic Pain.

Based on Geography, the Anticonvulsants Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Anticonvulsants Market including Abbott Laboratories, Astrazeneca PLC, Bausch Health Companies Inc., Biocon Limited, Cadila Pharmaceuticals Limited, Cipla, Inc., Eisai Co., Ltd. by Royalty Pharma, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., GW Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Lundbeck A/S, Mankind Pharma Ltd, Merck KGaA, Novartis AG, Novo Nordisk A/S, Otsuka Pharmaceutical, Pfizer Inc., Sanofi S.A, Sunovion Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Wockhardt Limited.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anticonvulsants Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Anticonvulsants Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anticonvulsants Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anticonvulsants Market?
4. What is the competitive strategic window for opportunities in the Global Anticonvulsants Market?
5. What are the technology trends and regulatory frameworks in the Global Anticonvulsants Market?
6. What are the modes and strategic moves considered suitable for entering the Global Anticonvulsants Market?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biocon Limited
  • GlaxoSmithKline PLC
  • Lundbeck A/S
  • Merck KGaA
  • Novo Nordisk A/S
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Drug types Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalences of epilepsy
5.1.1.2. Rising investment and support from the government
5.1.2. Restraints
5.1.2.1. Patent expiration of the second-generation drugs
5.1.2.2. Availability of substitutes options for pain management
5.1.3. Opportunities
5.1.3.1. Rising drug approvals of anticonvulsant drugs from regulatory bodies
5.1.4. Challenges
5.1.4.1. Steep rise in medicine supply shortage for patients
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Anticonvulsants Market, By Drug types
6.1. Introduction
6.2. AMPA
6.3. Barbiturate
6.4. Benzodiazepine
6.5. Carbamate Anticonvulsants
6.6. Carbonic Anhydrase Inhibitor
6.7. Dibenzazepine
6.8. Triazine

7. Global Anticonvulsants Market, By Application
7.1. Introduction
7.2. Anxiety
7.3. Bipolar Disorder
7.4. Borderline Personality Disorder.
7.5. Epilepsy
7.6. Fibromyalgia
7.7. Migraine
7.8. Neuropathic Pain

8. Americas Anticonvulsants Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Anticonvulsants Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand

10. Europe, Middle East & Africa Anticonvulsants Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Astrazeneca PLC
12.3. Bausch Health Companies Inc.
12.4. Biocon Limited
12.5. Cadila Pharmaceuticals Limited
12.6. Cipla, Inc.
12.7. Eisai Co., Ltd. by Royalty Pharma
12.8. GlaxoSmithKline PLC
12.9. Glenmark Pharmaceuticals Ltd.
12.10. GW Pharmaceuticals PLC
12.11. Johnson & Johnson Services, Inc.
12.12. Lundbeck A/S
12.13. Mankind Pharma Ltd
12.14. Merck KGaA
12.15. Novartis AG
12.16. Novo Nordisk A/S
12.17. Otsuka Pharmaceutical
12.18. Pfizer Inc.
12.19. Sanofi S.A
12.20. Sunovion Pharmaceuticals Inc.
12.21. Takeda Pharmaceutical Company Limited
12.22. Teva Pharmaceutical Industries Ltd.
12.23. Wockhardt Limited

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
Figure 1. Global Anticonvulsants Market: Research Process
Figure 2. Global Anticonvulsants Market: Research Execution
Figure 3. Global Anticonvulsants Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Anticonvulsants Market Size, by Drug Types, 2020 (USD Million)
Figure 5. Global Anticonvulsants Market Size, by Application , 2020 (USD Million)
Figure 6. Global Anticonvulsants Market Size, by Geography, 2020 (USD Million)
Figure 7. Global Anticonvulsants Market Size, 2018-2025 (USD Million)
Figure 8. Global Anticonvulsants Market Size, by Geography, 2020 Vs 2025 (%)
Figure 9. Global Anticonvulsants Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 10. Competitive Strategic Window for Global Anticonvulsants Market Size, by Geography, 2025
Figure 11. Global Anticonvulsants Market: Market Dynamics
Figure 12. Global Anticonvulsants Market: Porters Five Forces Analysis
Figure 13. Global Anticonvulsants Market Size, by Drug Types, 2020 Vs 2025 (%)
Figure 14. Global Anticonvulsants Market Size, by Drug Types, 2020 Vs 2025 (USD Million)
Figure 15. Competitive Strategic Window for Global Anticonvulsants Market Size, by Drug Types, 2025
Figure 16. Global Anticonvulsants Market Size, by Ampa, 2020 Vs 2025 (USD Million)
Figure 17. Global Anticonvulsants Market Size, by Barbiturate, 2020 Vs 2025 (USD Million)
Figure 18. Global Anticonvulsants Market Size, by Benzodiazepine, 2020 Vs 2025 (USD Million)
Figure 19. Global Anticonvulsants Market Size, by Carbamate Anticonvulsants, 2020 Vs 2025 (USD Million)
Figure 20. Global Anticonvulsants Market Size, by Carbonic Anhydrase Inhibitor, 2020 Vs 2025 (USD Million)
Figure 21. Global Anticonvulsants Market Size, by Dibenzazepine, 2020 Vs 2025 (USD Million)
Figure 22. Global Anticonvulsants Market Size, by Triazine, 2020 Vs 2025 (USD Million)
Figure 23. Global Anticonvulsants Market Size, by Application , 2020 Vs 2025 (%)
Figure 24. Global Anticonvulsants Market Size, by Application , 2020 Vs 2025 (USD Million)
Figure 25. Competitive Strategic Window for Global Anticonvulsants Market Size, by Application , 2025
Figure 26. Global Anticonvulsants Market Size, by Anxiety, 2020 Vs 2025 (USD Million)
Figure 27. Global Anticonvulsants Market Size, by Bipolar Disorder, 2020 Vs 2025 (USD Million)
Figure 28. Global Anticonvulsants Market Size, by Borderline Personality Disorder., 2020 Vs 2025 (USD Million)
Figure 29. Global Anticonvulsants Market Size, by Epilepsy, 2020 Vs 2025 (USD Million)
Figure 30. Global Anticonvulsants Market Size, by Fibromyalgia, 2020 Vs 2025 (USD Million)
Figure 31. Global Anticonvulsants Market Size, by Migraine, 2020 Vs 2025 (USD Million)
Figure 32. Global Anticonvulsants Market Size, by Neuropathic Pain, 2020 Vs 2025 (USD Million)
Figure 33. Americas Anticonvulsants Market Size, by Geography, 2020 Vs 2025 (%)
Figure 34. Americas Anticonvulsants Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 35. Competitive Strategic Window for Americas Anticonvulsants Market Size, by Geography, 2025
Figure 36. Argentina Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 37. Brazil Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 38. Canada Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 39. Mexico Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 40. United States Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. Asia-Pacific Anticonvulsants Market Size, by Geography, 2020 Vs 2025 (%)
Figure 42. Asia-Pacific Anticonvulsants Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 43. Competitive Strategic Window for Asia-Pacific Anticonvulsants Market Size, by Geography, 2025
Figure 44. Australia Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 45. China Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 46. India Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. Indonesia Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. Japan Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. Malaysia Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. Philippines Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. South Korea Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. Thailand Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. Europe, Middle East & Africa Anticonvulsants Market Size, by Geography, 2020 Vs 2025 (%)
Figure 54. Europe, Middle East & Africa Anticonvulsants Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 55. Competitive Strategic Window for Europe, Middle East & Africa Anticonvulsants Market Size, by Geography, 2025
Figure 56. France Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 57. Germany Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 58. Italy Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. Netherlands Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Qatar Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 61. Russia Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 62. Saudi Arabia Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. South Africa Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. Spain Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. United Arab Emirates Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. United Kingdom Anticonvulsants Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. Global Anticonvulsants Market: Fpnv Positioning Matrix
Figure 68. Global Anticonvulsants Market: Market Share Analysis
Figure 69. Global Anticonvulsants Market: Competitor SWOT Analysis
Figure 70. Competitive Scenario Analysis in Global Anticonvulsants Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Anticonvulsants Market Size, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 3. Global Anticonvulsants Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 4. Global Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 5. Global Anticonvulsants Market Size, by Ampa, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 6. Global Anticonvulsants Market Size, by Barbiturate, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 7. Global Anticonvulsants Market Size, by Benzodiazepine, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 8. Global Anticonvulsants Market Size, by Carbamate Anticonvulsants, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 9. Global Anticonvulsants Market Size, by Carbonic Anhydrase Inhibitor, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 10. Global Anticonvulsants Market Size, by Dibenzazepine, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 11. Global Anticonvulsants Market Size, by Triazine, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 12. Global Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 13. Global Anticonvulsants Market Size, by Anxiety, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 14. Global Anticonvulsants Market Size, by Bipolar Disorder, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 15. Global Anticonvulsants Market Size, by Borderline Personality Disorder., by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 16. Global Anticonvulsants Market Size, by Epilepsy, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 17. Global Anticonvulsants Market Size, by Fibromyalgia, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 18. Global Anticonvulsants Market Size, by Migraine, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 19. Global Anticonvulsants Market Size, by Neuropathic Pain, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 20. Americas Anticonvulsants Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 21. Americas Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 22. Americas Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 23. Argentina Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 24. Argentina Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 25. Brazil Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 26. Brazil Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 27. Canada Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 28. Canada Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 29. Mexico Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 30. Mexico Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 31. United States Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 32. United States Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 33. Asia-Pacific Anticonvulsants Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 34. Asia-Pacific Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 35. Asia-Pacific Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 36. Australia Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 37. Australia Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 38. China Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 39. China Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 40. India Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 41. India Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 42. Indonesia Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 43. Indonesia Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 44. Japan Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 45. Japan Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 46. Malaysia Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 47. Malaysia Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 48. Philippines Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 49. Philippines Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 50. South Korea Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 51. South Korea Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 52. Thailand Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 53. Thailand Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 54. Europe, Middle East & Africa Anticonvulsants Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 55. Europe, Middle East & Africa Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 56. Europe, Middle East & Africa Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 57. France Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 58. France Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 59. Germany Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 60. Germany Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 61. Italy Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 62. Italy Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 63. Netherlands Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 64. Netherlands Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 65. Qatar Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 66. Qatar Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 67. Russia Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 68. Russia Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 69. Saudi Arabia Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 70. Saudi Arabia Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 71. South Africa Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 72. South Africa Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 73. Spain Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 74. Spain Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 75. United Arab Emirates Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 76. United Arab Emirates Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 77. United Kingdom Anticonvulsants Market Size, by Drug Types, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 78. United Kingdom Anticonvulsants Market Size, by Application , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 79. Global Anticonvulsants Market: Scores
Table 80. Global Anticonvulsants Market: Business Strategy
Table 81. Global Anticonvulsants Market: Product Satisfaction
Table 82. Global Anticonvulsants Market: Ranking
Table 83. Global Anticonvulsants Market: Merger & Acquisition
Table 84. Global Anticonvulsants Market: Agreement, Collaboration, & Partnership
Table 85. Global Anticonvulsants Market: New Product Launch & Enhancement
Table 86. Global Anticonvulsants Market: Investment & Funding
Table 87. Global Anticonvulsants Market: Award, Recognition, & Expansion
Table 88. Global Anticonvulsants Market: License & Pricing
Note: Product cover images may vary from those shown
3 of 4
  • Abbott Laboratories
  • Astrazeneca PLC
  • Bausch Health Companies Inc.
  • Biocon Limited
  • Cadila Pharmaceuticals Limited
  • Cipla, Inc.
  • Eisai Co., Ltd. by Royalty Pharma
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • GW Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • Lundbeck A/S
  • Mankind Pharma Ltd
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Otsuka Pharmaceutical
  • Pfizer Inc.
  • Sanofi S.A
  • Sunovion Pharmaceuticals Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Limited
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll